Arca Biopharma reported $31.78M in Current Liabilities for its fiscal quarter ending in September of 2026.





Current Liabilities Change Date
Alterity Therapeutics Limited AUD 1.73M 2.77M Dec/2025
Amgen USD 23.23B 2.27B Sep/2026
Arca Biopharma USD 31.78M 8.81M Sep/2026
Biogen USD 3.9B 18.7M Sep/2026
Brainstorm Cell Therapeutics USD 12.38M 621K Jun/2026
Bristol-Myers Squibb USD 18.75B 94M Sep/2026
Capricor Therapeutics USD 29.9M 3.07M Sep/2026
Cipla INR 69.77B 366.6M Sep/2026
Clal Biotechnology ILS 6.66M 3.75M Dec/2023
Compugen USD 22.63M 596K Jun/2026
CSL USD 4.61B 207M Dec/2025
Cytokinetics USD 353.42M 171.99M Sep/2026
Daiichi Sankyo JPY 882.78B 117.08B Sep/2026
Gilead Sciences USD 12B 982M Sep/2026
GlaxoSmithKline GBP 20.72B 814M Sep/2026
Grifols EUR 2.37B 156.97M Dec/2025
Laboratory Of America USD 2.82B 695M Sep/2026
Myriad Genetics USD 130.7M 500K Jun/2026
Otsuka Holdings JPY 701.98B 36.98B Sep/2026
Pfizer USD 31.73B 920M Sep/2026
United Therapeutics USD 624.3M 16.5M Sep/2026